Immune-related hepatitis related to checkpoint inhibitors: Clinical and prognostic factors

Autor: L Viladomiu, Carolina Ortiz-Velez, Judit Vidal-González, Ana Barreira-Díaz, Eva Muñoz-Couselo, Beatriz Minguez, Lluis Castells, Rafael Esteban, Mar Riveiro-Barciela, Fernando Martínez-Valle, Maria Buti

Publikováno v: Liver international : official journal of the International Association for the Study of the LiverREFERENCES. 40(8)

BACKGROUND & AIMS Check point inhibitors (CPI) have improved survival of oncology patients but adverse effects that mimic autoimmune disorders have been reported. Our aim was describe the characteristics of immune-related hepatitis (irH) and prognosi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bffd145b21a3e556ec66a9e7081f98ca
https://pubmed.ncbi.nlm.nih.gov/32329119

FRI-054-Immune-related hepatitis as an independent entity from autoimmune hepatitis: clinical, prognostic and therapeutic differences

Autor: Ana Barreira-Díaz, Judit Vidal-González, Mar Riveiro-Barciela, Fernando Martínez-Valle, Carolina Ortiz Velez, Rafael Esteban, L Viladomiu, Eva Muñoz-Couselo, Maria Buti, Lluis Castells

Publikováno v: Journal of Hepatology. 70:e408

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::09275630b6bf729330de1dd8da8f87b0
https://doi.org/10.1016/s0618-8278(19)30804-7

High-Resolution Hepatitis C Virus Subtyping Using NS5B Deep Sequencing and Phylogeny, an Alternative to Current Methods

Autor: Xavier Forns, Marta Bes, Javier García-Samaniego, Manuel Romero-Gómez, Rafael Esteban, Josep Gregori, Maria Buti, Julie Sheldon, Silvia Sauleda, Sofía Pérez-del-Pulgar, Maria Homs, Miguel Álvarez-Tejado, Celia Perales, David Tabernero, Rosa Quiles-Pérez, L Viladomiu, Jose Antonio delCampo, Jordi Gómez, Carlos Briones, Antonio Madejón, Sabela Lens, Jose Manuel Muñoz, Maria Blasi, Francisco Rodriguez-Frias, Lluis Castells, Rosario López-Rodríguez, Maria Cubero, Jaume Guardia, Rosario Casillas, Josep Quer, Andrea Caballero, Damir Garcia-Cehic, Paloma Muñoz-de-Rueda, Paloma Sanz-Cameno, Juan Ignacio Esteban, Javier Salmerón, Irene Belmonte, Helena Allende, Ricardo Moreno-Otero, L. Nieto, Angela Ruiz-Extremera, Esteban Domingo

Publikováno v: Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
Digital.CSIC. Repositorio Institucional del CSIC

All Rights Reserved. HepatitisCvirus(HCV)is classified into seven major genotypesand67 subtypes. Recent studies haveshownthat inHCVgenotype 1-infected patients, response rates to regimens containingdirect-acting antivirals(DAAs)are subtype dependent.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c74b90d1df6e26cb872ca91ea2428039
https://europepmc.org/articles/PMC4290919/

Utility of early testing for HCV viremia as predictive factor of sustained response during interferon or interferon plus ribavirin treatment

Autor: Rafael Esteban, Silvia Sauleda, Francisco Castro, L Viladomiu, Elizabeth A. Dragon, Jaime Guardia, Juan Ignacio Esteban

Publikováno v: Journal of hepatology. 32(5)

To evaluate the utility of early testing for hepatitis C viremia as a predictor of treatment outcome during interferon or combination therapy.We studied 184 patients with chronic hepatitis C who received interferon and were monitored for HCV RNA. Six

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70fb54a7d8e79807953cf061a490d71a
https://pubmed.ncbi.nlm.nih.gov/10845673

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.